AVTR
NYSE HealthcareAvantor, Inc. Common Stock
Medical Instruments & Supplies
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
�� 市场数据
| 价格 | $8.52 |
|---|---|
| 成交量 | 11,949,570 |
| 市值 | 5.81B |
| 贝塔系数 | 1.000 |
| RSI(14日) | 83.2 超买 |
| 200日均线 | $11.48 |
| 50日均线 | $8.52 |
| 52周最高 | $16.17 |
| 52周最低 | $7.26 |
| Forward P/E | 9.97 |
| Price / Book | 1.03 |
🎯 投资策略评分
AVTR 在各投资策略中的评分。分数越高,越符合该策略目标。
🔍 策略解读
最佳匹配: 🔪 Falling Knife (81/100) — 此策略 逆向投资(超卖 + 低于移动均线).
评分最低的策略: 💰 Dividend Daddy (33/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 AVTR in your text
粘贴任何文章、记录或帖子 — 工具将提取 AVTR 以及每一个其他隐藏的股票代码。
免责声明:本数据仅供教育和娱乐用途,不构成金融建议。市场数据可能存在延迟。在做出投资决策之前,请始终进行自己的研究。
数据最后更新: 2026-04-17.